Condition: Non-Muscle Invasive Bladder Neoplasms · Sponsor: Janssen Research & Development, LLC
The main purpose of this study is to compare the disease-free survival (the length of time after randomization that a participant survives without any signs or symptoms of the cancer returning, or progressing) between Bacillus Calmette-Guérin (BCG) treated participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of high-risk non-muscle-invasive bladder cancer (HR-NMIBC).
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Academic Urology and Urogynecology of Arizona | Sun City, Arizona, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Recruiting |
| Colorado Clinical Research | Lakewood, Colorado, United States | Recruiting |
| Georgia Urology | Atlanta, Georgia, United States | Recruiting |
| Associated Urological Specialists | Chicago Ridge, Illinois, United States | Recruiting |
| Urology of Indiana | Carmel, Indiana, United States | Recruiting |
| Greater Boston Urology | Plymouth, Massachusetts, United States | Recruiting |
| Comprehensive Urology | Royal Oak, Michigan, United States | Recruiting |
| UroHealth Partners | Omaha, Nebraska, United States | Completed |
| New Jersey Urology LLC | Voorhees Township, New Jersey, United States | Recruiting |
| Associated Medical Professionals | Syracuse, New York, United States | Recruiting |
| Dayton Physicians Network Urology | Centerville, Ohio, United States | Recruiting |
+ 98 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06919965